79.45
Healthequity Inc stock is traded at $79.45, with a volume of 1.15M.
It is up +0.29% in the last 24 hours and down -16.76% over the past month.
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
See More
Previous Close:
$79.22
Open:
$79.7
24h Volume:
1.15M
Relative Volume:
1.23
Market Cap:
$6.79B
Revenue:
$1.15B
Net Income/Loss:
$96.70M
P/E Ratio:
72.89
EPS:
1.09
Net Cash Flow:
$-161.99M
1W Performance:
-7.26%
1M Performance:
-16.76%
6M Performance:
-12.64%
1Y Performance:
-29.11%
Healthequity Inc Stock (HQY) Company Profile
Name
Healthequity Inc
Sector
Industry
Phone
801-727-1000
Address
15 WEST SCENIC POINTE DRIVE, DRAPER, UT
Compare HQY vs VEEV, TEM, BTSG, DOCS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
HQY
Healthequity Inc
|
79.45 | 6.77B | 1.15B | 96.70M | -161.99M | 1.09 |
|
VEEV
Veeva Systems Inc
|
183.65 | 30.22B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
54.91 | 9.33B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
39.68 | 6.92B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
DOCS
Doximity Inc
|
27.73 | 6.27B | 550.17M | 201.35M | 232.07M | 1.00 |
Healthequity Inc Stock (HQY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-09-26 | Downgrade | Goldman | Neutral → Sell |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| May-22-25 | Resumed | RBC Capital Mkts | Outperform |
| Mar-25-25 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-04-24 | Initiated | Mizuho | Outperform |
| Nov-15-24 | Initiated | Goldman | Neutral |
| Apr-04-24 | Initiated | JMP Securities | Mkt Outperform |
| Apr-02-24 | Reiterated | JP Morgan | Overweight |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-21-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-21-22 | Upgrade | Goldman | Sell → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-12-22 | Initiated | Goldman | Sell |
| Apr-11-22 | Initiated | Wells Fargo | Overweight |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Mar-30-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-07-21 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Sep-09-21 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Jul-02-21 | Initiated | Stephens | Overweight |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Jan-07-21 | Initiated | BTIG Research | Neutral |
| Dec-08-20 | Reiterated | Barrington Research | Outperform |
| Dec-02-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Nov-23-20 | Downgrade | Guggenheim | Buy → Neutral |
| Oct-23-20 | Initiated | RBC Capital Mkts | Outperform |
| Apr-14-20 | Initiated | Guggenheim | Buy |
| Apr-13-20 | Initiated | SVB Leerink | Mkt Perform |
| Mar-17-20 | Reiterated | Barrington Research | Outperform |
| Oct-07-19 | Initiated | Goldman | Neutral |
| Sep-09-19 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jul-19-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jun-05-19 | Reiterated | BofA/Merrill | Neutral |
| Mar-01-19 | Reiterated | BofA/Merrill | Neutral |
| Feb-07-19 | Reiterated | Chardan Capital Markets | Buy |
| Feb-07-19 | Upgrade | SunTrust | Hold → Buy |
| Dec-06-18 | Downgrade | SunTrust | Buy → Hold |
| Sep-06-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| May-23-18 | Initiated | BofA/Merrill | Buy |
| Apr-24-18 | Resumed | JP Morgan | Overweight |
| Mar-20-18 | Reiterated | Chardan Capital Markets | Buy |
| Dec-06-17 | Reiterated | Chardan Capital Markets | Buy |
View All
Healthequity Inc Stock (HQY) Latest News
Bessemer Group Inc. Raises Holdings in HealthEquity, Inc. $HQY - MarketBeat
Layoff Watch: Will HealthEquity Inc benefit from AI trendsQuarterly Portfolio Summary & Scalable Portfolio Growth Methods - baoquankhu1.vn
Is There An Opportunity With HealthEquity, Inc.'s (NASDAQ:HQY) 45% Undervaluation? - 富途牛牛
Trading Systems Reacting to (HQY) Volatility - Stock Traders Daily
HealthEquity, Inc. (NASDAQ:HQY) Sees Large Decline in Short Interest - MarketBeat
HealthEquity, Inc. (HQY) Investor Outlook: Unpacking A 39% Potential Upside - DirectorsTalk Interviews
Here's Why HealthEquity (HQY) is a Strong Growth Stock - Yahoo Finance
HealthEquity, Inc. $HQY Stock Position Lowered by New York State Common Retirement Fund - MarketBeat
HealthEquity’s Fiscal Year-End Sets Stage for March Financial Disclosure - AD HOC NEWS
How HealthEquity’s GARP Profile and Accelerating Earnings Narrative At HealthEquity (HQY) Has Changed Its Investment Story - Sahm
US Market Wrap: How does MBOT correlate with NasdaqShare Buyback & Risk Managed Investment Signals - baoquankhu1.vn
Earnings Miss: Is HealthEquity Inc stock technically oversoldJuly 2025 Reactions & Long-Term Safe Investment Plans - baoquankhu1.vn
HealthEquity Inc. (NASDAQ:HQY): A Prime GARP Candidate with Strong Growth and Reasonable Valuation - Chartmill
HealthEquity Inc (NASDAQ:HQY) Presents a Compelling Growth and Breakout Opportunity - Chartmill
Published on: 2026-01-28 07:33:41 - baoquankhu1.vn
Here's Why HealthEquity (NASDAQ:HQY) Has Caught The Eye Of Investors - Yahoo Finance
Strs Ohio Raises Holdings in HealthEquity, Inc. $HQY - MarketBeat
Published on: 2026-01-26 18:05:42 - baoquankhu1.vn
HealthEquity, Inc. (HQY) Investor Outlook: Explore the 41.63% Potential Upside and Analyst Confidence - DirectorsTalk Interviews
GDS Wealth Management Raises Stock Position in HealthEquity, Inc. $HQY - MarketBeat
How Healthequity Inc. (HQY) Affects Rotational Strategy Timing - Stock Traders Daily
Here's Why You Should Add HealthEquity Stock to Your Portfolio Now - sharewise.com
Did New FY 2027 Revenue Guidance and JPM Spotlight Just Shift HealthEquity's (HQY) Investment Narrative? - simplywall.st
Aug Sentiment: Is BlackRock Core Bond Trust stock a smart retirement pickMarket Performance Recap & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Aug Spikes: Will HealthEquity Inc stock benefit from M AJuly 2025 Recap & Consistent Return Strategy Ideas - baoquankhu1.vn
Published on: 2026-01-20 04:22:59 - baoquankhu1.vn
Profit Review: Does Knightscope Inc stock have upside surprise potentialBear Alert & Daily Volume Surge Signals - baoquankhu1.vn
The Truth About HealthEquity Inc: Why Wall Street Is Quietly Loading Up On HQY - AD HOC NEWS
We Think HealthEquity (NASDAQ:HQY) Can Stay On Top Of Its Debt - 富途资讯
HealthEquity (NASDAQ:HQY) Rating Increased to Buy at Wall Street Zen - MarketBeat
Stephens Investment Management Group LLC Has $68.64 Million Stock Holdings in HealthEquity, Inc. $HQY - MarketBeat
HQYHealthEquity Sets Date to Announce Third Quarter Results - ADVFN
New York Gov. Hochul Reveals Cannabis Initiatives Aimed at Supply Chain, Health Equity - Cannabis Equipment News
Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term - Yahoo Finance
HealthEquity, Inc. (NASDAQ:HQY) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
The Market's Not Diagnosing HealthEquity Accurately (NASDAQ:HQY) - Seeking Alpha
HealthEquity Reports Fourth Quarter and Fiscal Year Ended January 31, 2018 Financial Results - ADVFN
HealthEquity Reports Fourth Quarter and Fiscal Year Ended January 31, 2019 Financial Results - ADVFN
A Look At HealthEquity (HQY) Valuation As New Guidance And Split Analyst Calls Draw Attention - Sahm
HealthEquity Announces Year-End Sales Outlook, Presentation at JP Morgan Healthcare Conference - ADVFN
HealthEquity (NASDAQ:HQY) Trading Down 6.5%Here's Why - MarketBeat
HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2027 - marketscreener.com
HealthEquity expects FY 2027 revenue between $1.38B and $1.41B; shares down over 7% - MSN
HealthEquity stock slides nearly 10% after 2027 outlook; JPM conference is next test - TechStock²
HealthEquity drops after 2027 outlook misses estimates - TradingView — Track All Markets
Why Is HealthEquity’s Hot Streak Suddenly Faltering? - TipRanks
HealthEquity sees FY27 revenue $1.38B-$1.41B, consensus $1.41B - TipRanks
HealthEquity Expects Fiscal 2027 Revenue of $1.38 Billion to $1.41 Billion - marketscreener.com
HealthEquity Issues Confident Fiscal 2027 Outlook and Guidance - TipRanks
HealthEquity, Inc. Projects Fiscal Year 2027 Revenue Range and Reaffirms Fiscal Year 2026 Guidance - Quiver Quantitative
HealthEquity Announces Fiscal Year 2027 Outlook Presentation at J.P. Morgan Healthcare Conference - The Manila Times
Healthequity Inc Stock (HQY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):